High-fat Yogurt and Plasma Lipids Profile

April 14, 2023 updated by: Javad Nasrollahzadeh, Shahid Beheshti University

Comparison of the Impact of Saturated Fat From High-fat Yogurt or Low-fat Yogurt and Butter on Cardiometabolic Risk Markers: a Randomized Cross-over Trial

The goal of this clinical trial is to compare the effect of saturated fat intake from different source on cardiometabolic risk markers in healthy subjects. The main question it aims to answer are:

-Does intake of saturated fat in the form of high-fat yogurt have a different effect on cardiometabolic risk factors than intake of the same amount from butter? In this study, in two periods of 4 weeks, the effect of receiving saturated fat from high-fat yogurt compared to receiving the same amount of saturated fat from butter and low-fat yogurt on the plasma concentration of lipids, cholesterol, insulin, and some inflammatory factors will be studied in healthy subjects.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tehran, Iran, Islamic Republic of, 19395-4741
        • Clinical Nutrition Research Unit, National Nutrition and Food Technology Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy people who do not use lipid-lowering, blood pressure control or diabetes medications

Exclusion Criteria:

  • Taking supplements of omega-3 fatty acids, or antioxidants

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High-fat yogurt
Daily consumption of 1-2 servings (based on daily calorie requirement) of high-fat yogurt
Intake of saturated fat from yogurt and animal butter daily for 4-week period
Active Comparator: Low-fat yogurt and butter
Daily consumption of 1-2 servings of low-fat yogurt along with daily consumption of about 10 grams of animal butter
Intake of saturated fat from yogurt and animal butter daily for 4-week period

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plasma lipid profile
Time Frame: 4 weeks
Plasma concentrations of cholesterol, high-density lipoprotein cholesterol, Low-density lipoprotein cholesterol, and triglyceride
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycemic measures
Time Frame: 4 weeks
Fasting plasma concentrations of glucose and insulin
4 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inflammatory markers
Time Frame: 4 weeks
Plasma concentrations of c-reactive protein and interleukin 6
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2022

Primary Completion (Actual)

April 13, 2023

Study Completion (Actual)

April 13, 2023

Study Registration Dates

First Submitted

October 15, 2022

First Submitted That Met QC Criteria

October 18, 2022

First Posted (Actual)

October 21, 2022

Study Record Updates

Last Update Posted (Actual)

April 18, 2023

Last Update Submitted That Met QC Criteria

April 14, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 32333

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Plasma Lipid Profile

Clinical Trials on saturated fat intake

Subscribe